2m 2m 2m 2m 2m 2m 2m
BOLT BIOTHERAP (BOLT)
NASDAQ
$3.68+$0.010 (+0.27%)
Price as of Aug 21, 2026 7:17 PM EDT- $7.1MMarket Cap
- -28.83%1-Year Change
- BiotechnologyIndustry
BOLT BIOTHERAP (BOLT)
$3.68+$0.010 (+0.27%)
BOLT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.67 | ||
Change | +$0.47 (+14.53%) | ||
Open | $3.24 | ||
High | $3.78 | ||
Low | $3.20 | ||
Previous Close | $3.20 | ||
Volume | 65,317 | ||
30-Day Average Volume | 25,113 | ||
1-Week Change | 9.40% | ||
1-Month Change | -8.83% | ||
1-Year Change | -28.83% | ||
3-Year Change | -84.07% | ||
5-Year Change | -98.67% | ||
Fundamentals | |||
Shares Outstanding | 1.9M | ||
Total Assets | $40.3M | ||
Market Cap | $7.1M | ||
Enterprise Value | -$5.8M | ||
Period: QTR TTM FY | |||
Revenue | $5,000.00 | ||
Net Income | -$7.7M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$7.7M | ||
EBITDA | -$7.5M | ||
Net Working Capital | $12.7M | ||
EPS | -$4.57 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -1,160 | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue